| Effect of Noninvasive Neuromodulation on Chronic Pain (NCT03285685) | Federal University of Paraíba | 2017-10-02 |
| Safety and Efficacy of Nemolizumab in PN (NCT03181503) | Galderma R&D | 2017-10-02 |
| Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT03184571) | BerGenBio ASA | 2017-10-02 |
| Comparing Dexmedetomidine With Bupivacaine Versus Bupivacaine Alone for Caudal Block in Supra - Umbilical Surgeries (NCT03307590) | Cairo University | 2017-10-01 |
| Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia (NCT03404739) | Shanghai Zhongshan Hospital | 2017-10-01 |
| IL-1ra Dose-range Study for Moderate-to-severe TBI Patients (NCT02997371) | Adel Helmy | 2017-10-01 |
| REO13 Melanoma With of Without GM-CSF (NCT03282188) | University of Leeds | 2017-10-01 |
| Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD (NCT03135054) | The University of Hong Kong | 2017-10-01 |
| Posaconazole vs Itraconazole in Preventing IFD Post-HSCT (NCT03631602) | Fujian Medical University | 2017-10-01 |
| Specifying and Treating Anxiety in Autism Research (NCT03279471) | University of California, Davis | 2017-10-01 |
| Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS) (NCT03168711) | Massachusetts General Hospital | 2017-10-01 |
| Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients (NCT03303144) | Rockwell Medical Technologies, Inc. | 2017-10-01 |
| Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma (NCT02728245) | Seoul National University Hospital | 2017-10-01 |
| Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer (NCT03298074) | Yang Zhijun | 2017-10-01 |
| 2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma (NCT03168100) | University of Arkansas | 2017-10-01 |
| The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration. (NCT03205124) | University of Alberta | 2017-10-01 |
| Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT (NCT03320915) | Seoul National University Hospital | 2017-10-01 |
| A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT03267121) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2017-10-01 |
| Gabapentin for Bipolar & Cannabis Use Disorders (NCT03334721) | Medical University of South Carolina | 2017-10-01 |
| Stereotactic Body Radiotherapy for the Treatment of Solitary Bone Plasmacytoma (NCT03312868) | Instituto do Cancer do Estado de São Paulo | 2017-10-01 |
| PIPAC for Peritoneal Metastases of Colorectal Cancer (NCT03246321) | Koen Rovers | 2017-10-01 |
| Durvalumab in DLBCL After Autologous Transplant (NCT03241017) | Insel Gruppe AG, University Hospital Bern | 2017-10-01 |
| Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis (NCT04480359) | Shanghai University of Traditional Chinese Medicine | 2017-10-01 |
| A Self-Management Energy Conservation Program for Cancer-Related Fatigue (NCT03282214) | University of Michigan | 2017-10-01 |
| A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma (NCT03299322) | Shanghai University of Traditional Chinese Medicine | 2017-10-01 |
| Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma (NCT03660449) | Sun Yat-sen University | 2017-10-01 |
| A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand (NCT03302858) | Stephen E. Goldstone | 2017-10-01 |
| Azacitidine and Pembrolizumab in Pancreatic Cancer (NCT03264404) | Susan E. Bates | 2017-10-01 |
| Effects of Marijuana on Symptoms of OCD (NCT03274440) | New York State Psychiatric Institute | 2017-10-01 |
| Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures (NCT02679560) | Ian Elliott Brown | 2017-10-01 |
| Impact of Escitalopram on Sperm DNA Fragmentation (NCT03527043) | Weill Medical College of Cornell University | 2017-10-01 |
| Misoprostol for Cervical Priming Before Office Hysteroscopy (NCT03276000) | Kasr El Aini Hospital | 2017-10-01 |
| Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer (NCT03334591) | Anhui Provincial Hospital | 2017-10-01 |
| Effect of VSL#3 on Bone Mineral Density in Postmenopausal Women (NCT03165747) | Emory University | 2017-10-01 |
| A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules (NCT03340961) | Dr. Reddy's Laboratories Limited | 2017-10-01 |
| Rituximab, Cyclophosphamide, Vincristine and Prednisone (R-CHOP) Plus Metformin in Diffuse Large-B-cell Lymphoma (NCT03200015) | Hospital Universitario Dr. Jose E. Gonzalez | 2017-10-01 |
| Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) (NCT03143491) | DFB Soria, LLC | 2017-10-01 |
| Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer (NCT04425681) | Second Affiliated Hospital of Nanchang University | 2017-10-01 |
| Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer (NCT03150836) | Terence Friedlander, MD | 2017-10-01 |
| Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients (NCT03278015) | Chinese PLA General Hospital | 2017-10-01 |
| Ebselen as an add-on Treatment in Hypo/Mania (NCT03013400) | University of Oxford | 2017-10-01 |
| Platelet Inhibition to Target Reperfusion Injury (NCT03102723) | National Heart Centre Singapore | 2017-10-01 |
| Cerclage for Twins With Short Cervix (NCT03077633) | Pediatrix | 2017-10-01 |
| Open Label Immunotherapy of Endometriosis (NCT03340324) | Immunitor LLC | 2017-10-01 |
| Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia (NCT03280979) | Assiut University | 2017-10-01 |
| Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo (NCT03358082) | Sohag University | 2017-10-01 |
| Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF (NCT03071055) | Southeast Clinical Research Associates, LLC | 2017-10-01 |
| Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients (NCT03032614) | The University of Texas Health Science Center at San Antonio | 2017-09-30 |
| A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia (NCT03025698) | Novartis Pharmaceuticals | 2017-09-30 |
| F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD) (NCT02707978) | Tammie L. S. Benzinger, MD, PhD | 2017-09-30 |
| Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients (NCT03325621) | Pieris Pharmaceuticals GmbH | 2017-09-30 |
| Efficacy and Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Children on Antibiotics (NCT03181516) | Georgetown University | 2017-09-30 |
| Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor (NCT03395730) | Eslam Mohammed Abbas | 2017-09-30 |
| Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions. (NCT03208790) | Cairo University | 2017-09-30 |
| The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis (NCT03264625) | Peking University First Hospital | 2017-09-30 |
| Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants (NCT03308942) | Tesaro, Inc. | 2017-09-29 |
| A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate (NCT03257852) | Astellas Pharma Inc | 2017-09-29 |
| Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms (NCT03188991) | NanOlogy, LLC | 2017-09-29 |
| This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year (NCT03230097) | Boehringer Ingelheim | 2017-09-29 |
| Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer (NCT03323346) | The Institute of Molecular and Translational Medicine, Czech Republic | 2017-09-29 |
| Bendamustine + Obinutuzumab Induction With Obinutuzumab Maintenance in Untreated Mantle Cell Lymphoma (NCT03311126) | University of Wisconsin, Madison | 2017-09-29 |
| Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) (NCT03273712) | University of Iowa | 2017-09-29 |
| Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty (NCT04919317) | Temple University | 2017-09-29 |
| Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer (NCT03257163) | Rutgers, The State University of New Jersey | 2017-09-29 |
| Effect of a Propolis Tablet on the Saliva and the Amount of Adolescent Dental Plaque Microbes (NCT03394729) | Universidade Federal do Rio de Janeiro | 2017-09-29 |
| Controlled Trial Evaluating Avacopan in C3 Glomerulopathy (NCT03301467) | Amgen | 2017-09-29 |
| The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma (NCT03242824) | Mayo Clinic | 2017-09-29 |
| Targeted Microbiome Transplant in Atopic Dermatitis (NCT03151148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-09-28 |
| X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib (NCT03215693) | Betta Pharmaceuticals Co., Ltd. | 2017-09-28 |
| Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. (NCT03213301) | Swiss Cancer Institute | 2017-09-28 |
| Afrezza Safety and Pharmacokinetics Study in Pediatric Patients (NCT02527265) | Mannkind Corporation | 2017-09-28 |
| Nutrition and Exercise in Critical Illness (NCT03021902) | Clinical Evaluation Research Unit at Kingston General Hospital | 2017-09-28 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer (NCT03222076) | M.D. Anderson Cancer Center | 2017-09-28 |
| MUK Nine b: OPTIMUM Treatment Protocol (NCT03188172) | University of Leeds | 2017-09-28 |
| Study of Angiogenic Cell Therapy for Progressive Pulmonary Hypertension (NCT03001414) | Northern Therapeutics | 2017-09-28 |
| Immediate or Deferred Pre-exposure Prophylaxis for HIV Prevention: Safe Options for Pregnant and Lactating Women (NCT03227731) | University of KwaZulu | 2017-09-28 |
| Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma (NCT03149822) | University of Colorado, Denver | 2017-09-28 |
| Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa (NCT03275870) | Elena Gonzalez Brant, MD | 2017-09-28 |
| Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age (NCT03276962) | GlaxoSmithKline | 2017-09-28 |
| NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer (NCT03146663) | NuCana plc | 2017-09-28 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease (NCT03257046) | Intra-Cellular Therapies, Inc. | 2017-09-28 |
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT03074318) | Fred Hutchinson Cancer Center | 2017-09-28 |
| A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis (NCT03282318) | Astellas Pharma Europe B.V. | 2017-09-28 |
| Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (NCT03230318) | Basilea Pharmaceutica | 2017-09-28 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease (NCT03325790) | Sound Pharmaceuticals, Incorporated | 2017-09-28 |
| Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing (NCT03109015) | Duke University | 2017-09-27 |
| MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma (NCT03218163) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-09-27 |
| 6-week Safety and PD Study in Adults With NAFLD (NCT03256526) | Pfizer | 2017-09-27 |
| L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release (NCT03534661) | University Health Network, Toronto | 2017-09-27 |
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers (NCT02978625) | National Cancer Institute (NCI) | 2017-09-27 |
| Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer (NCT03106415) | Mayo Clinic | 2017-09-27 |
| Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance (NCT03330275) | Johnson & Johnson Vision Care, Inc. | 2017-09-27 |
| Safety, Pharmacokinetics and Pharmacodynamics Study of Inhaled QBW276 in Patients With Cystic Fibrosis (NCT02566044) | Novartis Pharmaceuticals | 2017-09-27 |
| A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG) (NCT03268941) | Millennium Pharmaceuticals, Inc. | 2017-09-26 |
| Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease (NCT03295786) | Herantis Pharma Plc. | 2017-09-26 |
| To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) (NCT03220217) | Ipsen | 2017-09-26 |
| Pembrolizumab + Idelalisib for Lung Cancer Study (NCT03257722) | Asha Nayak | 2017-09-26 |
| Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia (NCT03214562) | M.D. Anderson Cancer Center | 2017-09-26 |
| Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department (NCT03256487) | Alameda Health System | 2017-09-26 |